Literature DB >> 10202607

Cytokine production in panic disorder patients.

R Weizman1, N Laor, Z Wiener, L Wolmer, H Bessler.   

Abstract

Based on findings that stress and anxiety may modulate immune function, we compared the production of interleukin-2 (IL-2) and interleukin-3 (IL-3) by peripheral blood mononuclear cells between 24 patients with nonmajor depressed panic disorders, 9 with agoraphobia and 15 without, and 19 healthy volunteers. No differences in the production of these cytokines was noted between the patients with panic disorders and the volunteers or between the patients with and without agoraphobia. However, in the patients, a negative correlation was found for interleukin-3 production with severity of state anxiety, but not with trait anxiety or depression. This finding indicates that interleukin-3 levels may be sensitive to the presence of anxiety and stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202607     DOI: 10.1097/00002826-199903000-00008

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  6 in total

Review 1.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 2.  Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets.

Authors:  David S Baldwin; Ruihua Hou; Robert Gordon; Nathan T M Huneke; Matthew Garner
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

3.  Lymphocyte subsets and mood states in panic disorder patients.

Authors:  Joo-Eon Park; Sang-Wook Kim; Quehn Park; Do-Un Jeong; Bum-Hee Yu
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

4.  Effects of experimentally induced panic attacks on neuroimmunological markers.

Authors:  L de la Fontaine; M J Schwarz; D Eser; N Müller; R Rupprecht; P Zwanzger
Journal:  J Neural Transm (Vienna)       Date:  2008-11-21       Impact factor: 3.575

5.  Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study.

Authors:  Ruihua Hou; Matthew Garner; Clive Holmes; Clive Osmond; Jessica Teeling; Laurie Lau; David S Baldwin
Journal:  Brain Behav Immun       Date:  2017-02-01       Impact factor: 7.217

6.  Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain.

Authors:  Itziar Gil-Pisa; Carolina Cebrián; Jorge E Ortega; J Javier Meana; David Sulzer
Journal:  J Neuroinflammation       Date:  2014-07-29       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.